Isbn: 9789401797313 - Kinesins and Cancer (9 results)

ISBN: 
Refine with Advanced Search

Refine your search

  • Books (9)

to

Custom price range (£)

to

  • Language: English

    Published by Springer, 2015

    9401797315 / 9789401797313

    • Hardcover

    Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections

    5-star seller
    Contact seller

    Condition: New

    £ 106.66

    £ 11.29 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: Over 20 available

    Condition: New. In English.

  • Language: English

    Published by Springer, 2015

    9401797315 / 9789401797313

    • Hardcover

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    £ 104.67

    £ 30.10 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.…

  • Language: English

    Published by Springer, 2015

    9401797315 / 9789401797313

    • Hardcover

    Seller: Revaluation Books, Exeter, United KingdomRevaluation Books

    5-star seller
    Contact seller

    Condition: New

    £ 131.51

    £ 12.50 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 2 available

    Hardcover. Condition: Brand New. 1st edition. 271 pages. 9.25x6.25x0.75 inches. In Stock.

  • Language: English

    Published by Springer Netherlands, 2015

    9401797315 / 9789401797313

    • Hardcover

    Seller: Buchpark, Trebbin, GermanyBuchpark

    5-star seller
    Contact seller

    Condition: Used - Fine

    £ 74.10

    £ 90.30 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Condition: Sehr gut. Zustand: Sehr gut | Seiten: 284 | Sprache: Englisch | Produktart: Bücher | This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.…

  • Language: English

    Published by Springer, 2015

    9401797315 / 9789401797313

    • Hardcover

    Seller: Mispah books, Redhill, SURRE, United KingdomMispah books

    4-star seller
    Contact seller

    Condition: Used - As new

    £ 154.00

    £ 25.00 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

  • Language: English

    Published by Springer, 2015

    9401797315 / 9789401797313

    • Hardcover
    • Print on Demand

    Seller: Brook Bookstore On Demand, Napoli, NA, ItalyBrook Bookstore On Demand

    5-star seller
    Contact seller

    Condition: New

    £ 76.40

    £ 5.85 shipping 
    Ships from Italy to U.S.A.

    Quantity: Over 20 available

    Condition: new. Questo è un articolo print on demand.

  • Language: English

    Published by Springer Netherlands Mrz 2015, 2015

    9401797315 / 9789401797313

    • Hardcover
    • Print on Demand

    Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.

    5-star seller
    Contact seller

    Condition: New

    £ 94.77

    £ 19.78 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail. 284 pp. Englisch.…

  • Language: English

    Published by Springer Netherlands, 2015

    9401797315 / 9789401797313

    • Hardcover
    • Print on Demand

    Seller: moluna, Greven, Germanymoluna

    5-star seller
    Contact seller

    Condition: New

    £ 81.74

    £ 42.13 shipping 
    Ships from Germany to U.S.A.

    Quantity: Over 20 available

    Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covers the entire, interdisciplinary field of kinesins and cancer through expert contributionsOffers a timely reference standard on the relevance of kinesins to cancer treatmentContributes to potential initial validation of mitotic ki.…

  • Language: English

    Published by Springer, Springer Mär 2015, 2015

    9401797315 / 9789401797313

    • Hardcover
    • Print on Demand

    Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000

    5-star seller
    Contact seller

    Condition: New

    £ 94.77

    £ 51.60 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 284 pp. Englisch.…